Literature DB >> 28254245

Design of a Multisite Study Assessing the Impact of Tic Disorders on Individuals, Families, and Communities.

E F Augustine1, H R Adams2, R H Bitsko3, E van Wijngaarden4, A H Claussen3, A Thatcher2, C E Hanks5, A B Lewin5, T G O'Connor6, A Vierhile2, M L Danielson3, R Kurlan7, T K Murphy5, J W Mink2.   

Abstract

BACKGROUND: Tic disorders, including Tourette syndrome, are complex, multisymptom diseases, yet the impact of these disorders on affected children, families, and communities is not well understood.
METHODS: To improve the understanding of the impacts of Tourette syndrome, two research groups conducted independent cross-sectional studies using qualitative and quantitative measures. They focused on similar themes, but distinct scientific objectives, and the sites collaborated to align methods of independent research proposals with the aim of increasing the analyzable sample size.
RESULTS: Site 1 (University of Rochester) was a Pediatric Neurology referral center. Site 2 (University of South Florida) was a Child Psychiatry referral center. A total of 205 children with tic disorders were enrolled from both studies. The University of Rochester also enrolled 100 control children in order to clearly isolate impacts of Tourette syndrome distinct from those occurring in the general population. The majority of children with tic disorders (n = 191, 93.1%) had Tourette syndrome, the primary population targeted for these studies. Children with Tourette syndrome were similar across sites in terms of tic severity and the occurrence of comorbid conditions. The occurrence of psychiatric comorbidities in the control group was comparable with that in the general pediatric population of the United States, making this a well-justified comparison group.
CONCLUSIONS: Through collaboration, two sites conducting independent research developed convergent research methods to enable pooling of data, and by extension increased power, for future analyses. This method of collaboration is a novel model for future epidemiological research of tic disorders.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Tourette syndrome; epidemiology; research design; research methods; tics

Mesh:

Year:  2016        PMID: 28254245      PMCID: PMC5440614          DOI: 10.1016/j.pediatrneurol.2016.10.017

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  36 in total

1.  Self-, parent-, and teacher-reported behavioral symptoms in youngsters with Tourette syndrome: a case-control study.

Authors:  Cristiano Termine; Claudia Selvini; Umberto Balottin; Chiara Luoni; Clare M Eddy; Andrea E Cavanna
Journal:  Eur J Paediatr Neurol       Date:  2011-01-26       Impact factor: 3.140

2.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

Review 3.  Mood disorders and Gilles de la Tourette's syndrome: An update on prevalence, etiology, comorbidity, clinical associations, and implications.

Authors:  Mary May Robertson
Journal:  J Psychosom Res       Date:  2006-09       Impact factor: 3.006

4.  The MAVRIC-C and MAVRIC-P: a preliminary reliability and validity study.

Authors:  Geoff Goodman; Jonathan N Bass; Douglas L Geenens; Charles W Popper
Journal:  J Pers Assess       Date:  2006-06

5.  Long term clinical course of Tourette syndrome.

Authors:  Renata Rizzo; Mariangela Gulisano; Paola Valeria Calì; Paolo Curatolo
Journal:  Brain Dev       Date:  2011-12-16       Impact factor: 1.961

6.  The behavioral spectrum of tic disorders: a community-based study.

Authors:  R Kurlan; P G Como; B Miller; D Palumbo; C Deeley; E M Andresen; S Eapen; M P McDermott
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

7.  Self injurious behaviour in Tourette syndrome: correlates with impulsivity and impulse control.

Authors:  C A Mathews; J Waller; D Glidden; T L Lowe; L D Herrera; C L Budman; G Erenberg; A Naarden; R D Bruun; N B Freimer; V I Reus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

8.  Frequency of obsessive-compulsive disorder in a community sample of young adolescents.

Authors:  L A Valleni-Basile; C Z Garrison; K L Jackson; J L Waller; R E McKeown; C L Addy; S P Cuffe
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Jul-Aug       Impact factor: 8.829

9.  Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome.

Authors:  Roger D Freeman
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

10.  A measure of functional impairment in youth with Tourette's syndrome.

Authors:  Eric A Storch; Caleb W Lack; Laura E Simons; Wayne K Goodman; Tanya K Murphy; Gary R Geffken
Journal:  J Pediatr Psychol       Date:  2007-05-23
View more
  3 in total

1.  Children from nuclear families with bad parental relationship could develop tic symptoms.

Authors:  Pengcheng Zhu; Min Wu; Pinxian Huang; Xin Zhao; Xiaoyi Ji
Journal:  Mol Genet Genomic Med       Date:  2020-05-18       Impact factor: 2.183

2.  Targeted Interventions in Tourette's using Advanced Neuroimaging and Stimulation (TITANS): study protocol for a double-blind, randomised controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area in children with Tourette's syndrome.

Authors:  Cynthia K Kahl; Rose Swansburg; Adam Kirton; Tamara Pringsheim; Gabrielle Wilcox; Ephrem Zewdie; Ashley Harris; Paul E Croarkin; Alberto Nettel-Aguirre; Sneha Chenji; Frank P MacMaster
Journal:  BMJ Open       Date:  2021-12-24       Impact factor: 2.692

3.  Anxiety Symptoms Differ in Youth With and Without Tic Disorders.

Authors:  Jennifer Vermilion; Carolina Pedraza; Erika F Augustine; Heather R Adams; Amy Vierhile; Adam B Lewin; Alyssa T Collins; Michael P McDermott; Thomas O'Connor; Roger Kurlan; Edwin van Wijngaarden; Tanya K Murphy; Jonathan W Mink
Journal:  Child Psychiatry Hum Dev       Date:  2021-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.